A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
An estimated 2.8 million people worldwide have multiple sclerosis (MS). This autoimmune condition is the result of the immune system damaging parts of the nerves in the brain and spinal cord, which ...
A distinct group of antibodies appear in blood samples of some people with multiple sclerosis years before they experience symptoms. The antibodies could help diagnose people with the condition sooner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results